<SEC-DOCUMENT>0000818479-25-000123.txt : 20250715
<SEC-HEADER>0000818479-25-000123.hdr.sgml : 20250715
<ACCEPTANCE-DATETIME>20250715163833
ACCESSION NUMBER:		0000818479-25-000123
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250711
FILED AS OF DATE:		20250715
DATE AS OF CHANGE:		20250715

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Frohning Andrea L.
		CENTRAL INDEX KEY:			0001591945
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16211
		FILM NUMBER:		251125228

	MAIL ADDRESS:	
		STREET 1:		C/O DENTSLY SIRONA INC
		STREET 2:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DENTSPLY SIRONA Inc.
		CENTRAL INDEX KEY:			0000818479
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				391434669
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607
		BUSINESS PHONE:		844-546-3722

	MAIL ADDRESS:	
		STREET 1:		13320 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277-3607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DENTSPLY INTERNATIONAL INC /DE/
		DATE OF NAME CHANGE:	19930630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GENDEX CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-07-11</periodOfReport>

    <issuer>
        <issuerCik>0000818479</issuerCik>
        <issuerName>DENTSPLY SIRONA Inc.</issuerName>
        <issuerTradingSymbol>XRAY</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001591945</rptOwnerCik>
            <rptOwnerName>Frohning Andrea L.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O DENTSPLY SIRONA INC</rptOwnerStreet1>
            <rptOwnerStreet2>13320-B BALLANTYNE CORPORATE PLACE</rptOwnerStreet2>
            <rptOwnerCity>CHARLOTTE</rptOwnerCity>
            <rptOwnerState>NC</rptOwnerState>
            <rptOwnerZipCode>28277</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>1</isOfficer>
            <officerTitle>SVP, CHRO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-07-11</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>304.664</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>34040.812</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Phantom Stock (Supplemental Executive Retirement Plan) SERP</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2025-07-11</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>16.7566</value>
                    <footnoteId id="F3"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>16.20</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16.7566</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1713.6525</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.</footnote>
        <footnote id="F2">Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.</footnote>
        <footnote id="F3">Comprised of phantom stock acquired as a result of accrued dividends.</footnote>
    </footnotes>

    <remarks>Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Jessica Causey, Attorney-IN-Fact for Andrea Frohning</signatureName>
        <signatureDate>2025-07-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>doc1.txt
<DESCRIPTION>POWER OF ATTORNEY (PUBLIC): FROHNING POA JC
<TEXT>
                  DENTSPLY SIRONA Inc.
Limited Power of Attorney for Section 16 Reporting Obligations

Know all by these presents that the undersigned hereby
constitutes and appoints each of Richard Rosenzweig, Jessica
Causey, and Lindi Barton-Brobst, or any of them acting singly
and with full power of substitution, the undersigned's true and
lawful attorney-in-fact to:

       1. Execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer or director or both of
DENTSPLY SIRONA Inc. (the "Company"), Forms 3, 4 and 5 (and any
amendments thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange
Act"), and the rules thereunder;

       2. To perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Forms 3, 4 or 5, complete and execute any
amendments thereto, and timely file such forms with the U.S.
Securities and Exchange Commission (the "SEC") and any
securities exchange or similar authority, including without
limitation the filing of a Form ID or any other documents
necessary or appropriate to enable the undersigned to file the
Forms 3, 4 and 5 electronically with the SEC;

       3. Seek or obtain, as the undersigned's representative
and on the undersigned's behalf, information on transactions in
the Company's securities from any third party, including
brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any
such information to each of the undersigned's attorneys-in-fact
appointed by this Limited Power of Attorney and approves and
ratifies any such release of information;

       4. Take any other action in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by or
for, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Limited Power of Attorney shall be in such form
and shall contain such information and disclosure as such
attorney-in-fact may approve in such attorney-in-fact's
discretion.

	The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and
thing whatsoever required, necessary or proper to be done in the
exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution
or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney and the rights and powers herein
granted.

           The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request
and on the behalf of the undersigned, are not assuming, nor is
the Company assuming, any of the undersigned's responsibilities
to comply with, or any liability for the failure to comply with,
any provision of Section 16 of the Exchange Act.
           This Limited Power of Attorney shall remain in full
force and effect until the undersigned is no longer required to
file Forms 3, 4 or 5 with respect to the undersigned's holdings
of and transactions in securities issued by the Company, unless
earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this Limited
Power of Attorney as of this 22nd day of May 2025.

Signed and acknowledged:



/s/
Andrea Frohning

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
